{
  "id": "1ca1ad17e02768b3",
  "title": "Emergent BioSolutions Receives U . S . FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg , Canada Site",
  "description": "20251212T143000Z",
  "content": "",
  "source": "portal.sina.com.hk",
  "source_url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/12/1407630/emergent-biosolutions-receives-u-s-fda-approval-for-drug-product-manufacturing-of-raxibacumab-at-its-winnipeg-canada-site/",
  "published_at": "20251212T143000Z",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "manufacturing",
    "drug"
  ],
  "location": "Hong Kong",
  "raw_data": {
    "url": "https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/12/12/1407630/emergent-biosolutions-receives-u-s-fda-approval-for-drug-product-manufacturing-of-raxibacumab-at-its-winnipeg-canada-site/",
    "url_mobile": "",
    "title": "Emergent BioSolutions Receives U . S . FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg , Canada Site",
    "seendate": "20251212T143000Z",
    "socialimage": "https://ml.globenewswire.com/media/ZmI5NDQxY2ItYTBiMy00YTliLTkzM2ItODBmYjM0ODBlZmI0LTEwMjI0MzktMjAyNS0xMi0xMi1lbg==/tiny/Emergent-Biosolutions-Inc-.png",
    "domain": "portal.sina.com.hk",
    "language": "English",
    "sourcecountry": "Hong Kong"
  }
}